[go: up one dir, main page]

FI942181A - Uudet lupaanijohdannaiset, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet - Google Patents

Uudet lupaanijohdannaiset, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet Download PDF

Info

Publication number
FI942181A
FI942181A FI942181A FI942181A FI942181A FI 942181 A FI942181 A FI 942181A FI 942181 A FI942181 A FI 942181A FI 942181 A FI942181 A FI 942181A FI 942181 A FI942181 A FI 942181A
Authority
FI
Finland
Prior art keywords
preparation
pharmaceutical preparations
preparations containing
lupane derivatives
new
Prior art date
Application number
FI942181A
Other languages
English (en)
Swedish (sv)
Other versions
FI942181A0 (fi
Inventor
Romaine Bouboutou
Norbert Dereu
Michel Evers
Jean-Christophe Gueguen
Claude James
Christele Poujade
Daniel Reisdorf
Yves Ribeill
Francoise Soler
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of FI942181A0 publication Critical patent/FI942181A0/fi
Publication of FI942181A publication Critical patent/FI942181A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI942181A 1991-11-13 1994-05-11 Uudet lupaanijohdannaiset, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet FI942181A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9113907A FR2683531B1 (fr) 1991-11-13 1991-11-13 Nouveaux derives du lupane, leur preparation et les compositions pharmaceutiques qui les contiennent.
PCT/FR1992/001046 WO1993010142A1 (fr) 1991-11-13 1992-11-12 Nouveaux derives du lupane, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
FI942181A0 FI942181A0 (fi) 1994-05-11
FI942181A true FI942181A (fi) 1994-05-11

Family

ID=9418832

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942181A FI942181A (fi) 1991-11-13 1994-05-11 Uudet lupaanijohdannaiset, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet

Country Status (11)

Country Link
US (1) US5468888A (fi)
EP (2) EP0542622A1 (fi)
CA (1) CA2121692A1 (fi)
FI (1) FI942181A (fi)
FR (1) FR2683531B1 (fi)
HU (1) HUT66959A (fi)
IL (1) IL103731A0 (fi)
MX (1) MX9206503A (fi)
TW (1) TW224103B (fi)
WO (1) WO1993010142A1 (fi)
YU (1) YU97492A (fi)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869535A (en) * 1995-03-21 1999-02-09 The Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma
US5658947A (en) * 1995-03-21 1997-08-19 Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma using betalinic acid
US5962527A (en) * 1995-03-21 1999-10-05 The Board Of Trustees Of The University Of Illinois Method and composition for treating cancers
US5679828A (en) * 1995-06-05 1997-10-21 Biotech Research Labs, Inc. Betulinic acid and dihydrobetulinic acid derivatives and uses therefor
EP0988311B9 (en) * 1997-06-04 2004-12-15 Cornell Research Foundation, Inc. Betulinol derivatives
US6403816B1 (en) * 1997-09-30 2002-06-11 Dabur Research Foundation Betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis
JP2002505337A (ja) * 1998-03-02 2002-02-19 ザ ユニバーシティ オブ ノース キャロライナ アット チャペル ヒル アシル化ベツリンおよびジヒドロベツリンの誘導体、その調製物、およびそれらの使用
US6369101B1 (en) 1999-02-26 2002-04-09 Regents Of The University Of Minnesota Therapeutic method to treat herpes virus infection
US6392070B1 (en) * 1999-08-10 2002-05-21 Regents Of The University Of Minnesota Birch bark processing and the isolation of natural products from birch bark
BR9917495A (pt) * 1999-09-09 2002-06-11 Dabur Res Foundation Derivados o ácido betulìnico tendo atividade antiangiogênica, processos para produzir tais derivados e sua utilização para o tratamento de antiogênese associada a tumores
WO2002016395A1 (en) * 2000-08-18 2002-02-28 The Board Of Trustees Of The University Of Illinois Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv
EP2567625A1 (en) * 2001-05-11 2013-03-13 University Of Ottawa Preparation containing betulinic acid, obtained from a plant of the family Marcgraviaceae
GB0128071D0 (en) * 2001-11-22 2002-01-16 Cyclacel Ltd Medicament
US20040265320A1 (en) * 2003-01-29 2004-12-30 Karl Salzwedel Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
US7537765B2 (en) * 2003-01-29 2009-05-26 Panacos Pharmaceuticals, Inc. Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
US7026305B2 (en) * 2003-04-14 2006-04-11 Meharry Medical College Anti-HIV agents with dual sites of action
US7326717B2 (en) * 2003-05-06 2008-02-05 L'oreal Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof
CA2560266A1 (en) * 2004-03-17 2005-09-29 Panacos Pharmaceuticals, Inc. Pharmaceutical salts of 3-o-(3',3'-dimethylsuccinyl) betulinic acid
WO2005112929A2 (en) * 2004-05-20 2005-12-01 Cornell Research Foundation, Inc. Anti-hiv-1 activity of betulinol derivatives
US7282521B2 (en) * 2004-05-24 2007-10-16 University Of North Carolina At Chapel Hill Anti-retroviral moronic acid derivatives
US20060154904A1 (en) * 2004-09-10 2006-07-13 Cornell Research Foundation, Inc. Betulinol derivatives as anti-HIV agents
TW200628161A (en) * 2004-11-12 2006-08-16 Panacos Pharmaceuticals Inc Novel betulin derivatives, preparation thereof and use thereof
US20060193804A1 (en) * 2005-02-24 2006-08-31 L'oreal Haircare use of cyclic amine derivatives
BRPI0610668A2 (pt) 2005-04-12 2010-07-13 Panacos Pharmaceuticals Inc polimorfas de di-n-metil-d-glucamina do ácido 3-o-(3',3'-dimetilsuccinil) betulìnico
WO2007002411A1 (en) * 2005-06-22 2007-01-04 Myriad Genetics, Inc. Antiviral compounds
JP2009527563A (ja) * 2006-02-21 2009-07-30 アキリオン ファーマシューティカルズ,インコーポレーテッド ウイルス感染症を治療するのに有用な置換タラキサスタン
US20080039428A1 (en) * 2006-06-29 2008-02-14 Panacos Pharmaceuticals, Inc. Antiretroviral combination therapy
US20090105203A1 (en) * 2006-10-16 2009-04-23 Myriad Genetics, Incorporated Compounds for treating viral infections
RU2317996C1 (ru) * 2006-10-30 2008-02-27 Институт нефтехимии и катализа РАН N'-{n-[3-оксо-лупан-28-оил]-9-аминононаноил}-3-амино-3-фенил-пропионовая кислота и ее соли как противовирусные и иммуностимулирующие агенты
US20090062243A1 (en) * 2007-08-03 2009-03-05 Advanced Life Sciences, Inc. Lupane-Type Triterpenoids Modified at 30-Position and Analogues Thereof
FR2920309B1 (fr) 2007-08-28 2010-05-28 Galderma Res & Dev Utilisation de travoprost pour traiter la chute des cheveux
WO2009090063A1 (en) * 2008-01-16 2009-07-23 Jado Technologies Gmbh Steroid sapogenin, androstane and triterpenoid sapogenin derivatives for the treatment and prevention of infectious diseases
FR2929118B1 (fr) 2008-03-28 2010-05-07 Oreal Utilisation de l'association de madecassoside et/ou de terminoloside et d'une arginine pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute
FR2929117B1 (fr) 2008-03-28 2010-05-07 Oreal Utilisation de l'association du 2,4-diaminopyrimidine 3-n-oxyde et du madecassosside et/ou du terminoloside pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute
KR100941595B1 (ko) * 2008-06-05 2010-02-11 주식회사 알앤엘바이오 바이러스 억제제로서 유용한 트리테르페노이드계 화합물
FR2949052B1 (fr) 2009-08-13 2015-03-27 Oreal Procede de traitement cosmetique du cuir chevelu.
CN102558280B (zh) * 2011-11-18 2014-09-17 温州大学 一种30-卤代桦木酸的生产方法
PL2838533T3 (pl) 2012-04-16 2018-03-30 Case Western Reserve University Kompozycje i sposoby modulowania aktywności 15-PGDH
EP2953960A1 (en) * 2013-02-06 2015-12-16 Bristol-Myers Squibb Company C-19 modified triterpenoids with hiv maturation inhibitory activity
JP6517197B2 (ja) 2013-10-15 2019-05-22 ケース ウエスタン リザーブ ユニバーシティ 短鎖デヒドロゲナーゼ活性を調節する組成物および方法
CN104045680B (zh) 2014-06-20 2016-09-14 东北林业大学 桦木醇的乙酰氨基酸酰类衍生物及其制备方法
AU2015357489A1 (en) 2014-12-05 2017-07-06 Case Western Reserve University Compositions and methods of modulating S-nitrosylation
PL227790B1 (pl) 2015-08-13 2018-01-31 Slaski Univ Medyczny W Katowicach Fosfoniany acetylenowych pochodnych betuliny o działaniu przeciwnowotworowym, sposób ich wytwarzania i zastosowanie.
US10688037B1 (en) 2015-12-31 2020-06-23 Nutraceutical Wellness Inc. Compositions and method for hair regrowth
US11690847B2 (en) 2016-11-30 2023-07-04 Case Western Reserve University Combinations of 15-PGDH inhibitors with corticosteroids and/or TNF inhibitors and uses thereof
JP2020514323A (ja) 2017-02-06 2020-05-21 ケース ウエスタン リザーブ ユニバーシティ 短鎖デヒドロゲナーゼ活性を調節する組成物と方法
PL237998B1 (pl) 2018-05-28 2021-06-28 Narodowy Inst Lekow Fosfonowe pochodne kwasu 3-karboksyacylobetulinowego, sposób ich otrzymywania oraz ich zastosowanie
EP3883577A4 (en) 2018-11-21 2022-06-15 Case Western Reserve University COMPOSITIONS AND METHODS FOR MODULATION OF SHORT CHAIN DEHYDROGENASE ACTIVITY
AU2021275122A1 (en) 2020-05-20 2022-12-15 Board Of Regents Of The University Of Texas System Compositions and methods of modulating short-chain dehydrogenase activity

Also Published As

Publication number Publication date
HU9401353D0 (en) 1994-08-29
YU97492A (sh) 1995-12-04
FR2683531B1 (fr) 1993-12-31
HUT66959A (en) 1995-01-30
IL103731A0 (en) 1993-04-04
FI942181A0 (fi) 1994-05-11
FR2683531A1 (fr) 1993-05-14
TW224103B (fi) 1994-05-21
US5468888A (en) 1995-11-21
WO1993010142A1 (fr) 1993-05-27
MX9206503A (es) 1993-05-01
EP0542622A1 (fr) 1993-05-19
CA2121692A1 (fr) 1993-05-27
EP0613483A1 (fr) 1994-09-07

Similar Documents

Publication Publication Date Title
FI942181A (fi) Uudet lupaanijohdannaiset, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
EE9400455A (et) Peptiidi derivaadid, nende valmistamise protsess, neid sisaldavad ravimpreparaadid ja nende kasutamine
EE03110B1 (et) Steroidi estrid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadid
IT8847556A0 (it) Derivati peptidici, loro preparazione e loro impiego come medicamenti
FI942913A (fi) Isatiinijohdannaiset, menetelmät niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
NO922005D0 (no) Farmasoeytiske preparater
FI943571A0 (fi) 1-bentseenisulfonyyli-1,3-dihydro-2H-bentsimidatsol-2-onijohdannaisia, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
DE3480599D1 (de) 1-hydroxypyrid-2-on-derivate enthaltende pharmazeutische zubereitungen.
IT8947823A0 (it) Derivati peptidici, loro preparazione e loro impiego come medicamenti
DE3483713D1 (de) Hydroxypyridon-derivate und sie enthaltende pharmazeutische zubereitungen.
EE03111B1 (et) Glükokortikosteroidi epimeerid, nende valmistamise protsessid ja neid sisaldavad ravimpreparaadid
DE69014351D1 (de) Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
DK489189D0 (da) Farmaceutisk praeparat
DE68917499D1 (de) Catechol-Derivate und sie enthaltende pharmazeutische Präparate.
IT1203743B (it) Peptidi e derivati peptidici,loro preparazione e loro impiego come medicamenti
DE3682960D1 (de) Pharmazeutische praeparate.
FI961938A0 (fi) Uudet taksoidit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
DK496889D0 (da) Peptidholdigt farmaceutisk praeparat
DK603988D0 (da) Farmaceutisk praeparat
EE9400148A (et) Tienotiasiini derivaadid, nende valmistamise meetod ja neid sisaldavad farmatseutilised preparaadid
DK635988A (da) 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater
DK336489A (da) Farmaceutisk praeparat
BR9106372A (pt) Derivados 1,5-benzotiazepinona,suas preparacoes e uso farmaceutico
KR900700471A (ko) 신규의 2,3-티오모르폴린디온-2-옥심유도체, 이들을 함유하는 약제학적 조성물 및 제법
NO924563D0 (no) Benzokinoksaliner, fremgangsmaate for deres fremstilling og farmasoeytiske preparater inneholdende de nevnte forbindelser